Mysthera Therapeutics
Latest round
- Seed
Last raised
- Aug 2023
Total raised
- $3.5M
Investors
- 1
About Mysthera Therapeutics
Based in Basel, Switzerland, and founded in 2023, Mysthera Therapeutics AG operates as a developer of therapeutics to treat autoimmune diseases, including glomerulonephritis, rheumatoid arthritis, and inflammatory bowel disease. The company is developing oral treatments for complex autoimmune diseases using PIM kinase inhibitors. These inhibitors target immune cell-related autoimmune disorders of different types. Their approach aims to balance the immune system without completely suppressing it, a challenge that current therapies haven't fully solved. Tertiary lymphoid structures (TLS), which are abnormal clusters of immune cells, play a crucial role. These structures form in tissues during long-term inflammation and are common in diseases like lupus nephritis, rheumatoid arthritis, and inflammatory bowel disease. The interactions between activated T and B cells triggered by CD40L-CD40 and STAT3 signalling cytokines lead to their formation. These inhibitors are intended to distinctly regulate the functions of immune cells across various lineages.
Who invested in Mysthera Therapeutics
1 investor across 1 round
See all investors in Mysthera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 21, 2023
Amount
$3.5M
Investors
Questions about Mysthera Therapeutics
Who invested in Mysthera Therapeutics?
Mysthera Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mysthera Therapeutics raised?
Mysthera Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mysthera Therapeutics last raise money?
Mysthera Therapeutics's most recent round on record is a Seed, in Aug 2023.
What does Mysthera Therapeutics do?
Based in Basel, Switzerland, and founded in 2023, Mysthera Therapeutics AG operates as a developer of therapeutics to treat autoimmune diseases, including glomerulonephritis, rheumatoid arthritis, and inflammatory bowel disease.
Where is Mysthera Therapeutics headquartered?
Mysthera Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Mysthera Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Mysthera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mysthera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.